WUXI BIOLOGICS-0,0000083

WUXI BIOLOGICS-0,0000083 Share · KYG970081173 · A2QJCN (LSSI) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of WUXI BIOLOGICS-0,0000083
No Price
30.04.2026 20:00
Current Prices from WUXI BIOLOGICS-0,0000083
ExchangeTickerCurrencyLast TradePriceDaily Change
OTC: UTC
UTC
WXIBF
USD
30.04.2026 20:00
4,70 USD
0,00 USD
XDUS: Düsseldorf
Düsseldorf
WUXIBC73.DUSB
EUR
30.04.2026 17:30
3,58 EUR
-0,11 EUR
-2,98 %
XHAM: Hamburg
Hamburg
WUXIBC73.HAMB
EUR
30.04.2026 06:07
3,62 EUR
-
XDQU: Quotrix
Quotrix
WUXIBC73.DUSD
EUR
30.04.2026 05:27
3,62 EUR
-
Invested Funds

The following funds have invested in WUXI BIOLOGICS-0,0000083:

Fund
iShares MSCI EM SRI UCITS ETF USD (Dist)
Vol. in million
8.314,50
Percentage (%)
3,68 %
Fund
iShares MSCI EM SRI UCITS ETF USD (Acc)
Vol. in million
94.061,62
Percentage (%)
3,68 %
Fund
iShares Dow Jones China Offshore 50 UCITS ETF (DE)
Vol. in million
3.013,13
Percentage (%)
3,58 %
Fund
iShares BRIC 50 UCITS ETF USD (Dist)
Vol. in million
6.102,62
Percentage (%)
2,81 %
Fund
iShares MSCI China UCITS ETF USD (Dist)
Vol. in million
60,60
Percentage (%)
1,84 %
Company Profile for WUXI BIOLOGICS-0,0000083 Share
WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development and manufacturing in the People's Republic of China, North America, Europe, and internationally. The company also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, and biologics clinical and manufacturing services; production and sale of medicals; vaccine CDMO and related business; and material supplier activities. WuXi Biologics (Cayman) Inc. has strategic partnership with ImmuneOncia Therapeutics, Legochem Biosciences Inc, Worg Pharma, OncoC4, and Exelixis Inc. The company was incorporated in 2014 and is headquartered in Wuxi, China.

Company Data

Name WUXI BIOLOGICS-0,0000083
Company WuXi Biologics (Cayman) Inc.
Website https://www.wuxibiologics.com
Primary Exchange LSSI Lang & Schwarz
WKN A2QJCN
ISIN KYG970081173
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Zhisheng Chen
Market Capitalization 19 Mrd.
Country China
Currency EUR
Employees 12,6 T
Address No. 108, Meiliang Road, 214092 Wuxi
IPO Date 2018-01-30

Stock Splits

Date Split
10.12.2020 3:1
16.11.2020 3:1

Ticker Symbols

Name Symbol
Over The Counter WXIBF
Düsseldorf WUXIBC73.DUSB
Frankfurt 1FW2.F
Hamburg WUXIBC73.HAMB
Quotrix WUXIBC73.DUSD
More Shares
Investors who hold WUXI BIOLOGICS-0,0000083 also have the following shares in their portfolio:
ALPHABET INC - CLASS A
ALPHABET INC - CLASS A Share
ENCAVIS AG
ENCAVIS AG Share
INIT INNOVATION
INIT INNOVATION Share
JD.COM. INC A
JD.COM. INC A Share
MBB SE
MBB SE Share
NOKIA CORP
NOKIA CORP Share
Nordea Invest Nordic Stars
Nordea Invest Nordic Stars Fund
RIO TINTO
RIO TINTO Share
SHOPIFY A SUB.VTG
SHOPIFY A SUB.VTG Share
STRATEC SE
STRATEC SE Share
Transaction Media Networks Inc.
Transaction Media Networks Inc. Share
VOLKSWAGEN AG Vorzugsaktie
VOLKSWAGEN AG Vorzugsaktie Share